A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity.
Saved in:
| Title: | A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity. |
|---|---|
| Authors: | Ashlaw EF; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA., Elfers CT; Seattle Children's Research Institute, Seattle, WA, 98195, USA; University of Washington School of Medicine, Department of Pediatrics, Seattle, WA, 98195, USA., Chichura KS; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA., Miranda IC; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA., McGivney A; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA., Chepurny OG; State University of New York, Upstate Medical University, Department of Medicine, Syracuse, NY, 13245, USA., Holz GG; State University of New York, Upstate Medical University, Department of Medicine, Syracuse, NY, 13245, USA; State University of New York, Upstate Medical University, Department of Pharmacology, Syracuse, NY, 13245, USA., Mullins G; Seattle Children's Research Institute, Seattle, WA, 98195, USA., den Hartigh LJ; University of Washington, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, UW Medicine Diabetes Institute, Seattle, WA, 98195, USA., Liu Y; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, 98195, USA., Roth CL; Seattle Children's Research Institute, Seattle, WA, 98195, USA; University of Washington School of Medicine, Department of Pediatrics, Seattle, WA, 98195, USA. Electronic address: Christian.roth@seattlechildrens.org., Doyle RP; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA; State University of New York, Upstate Medical University, Department of Medicine, Syracuse, NY, 13245, USA; State University of New York, Upstate Medical University, Department of Pharmacology, Syracuse, NY, 13245, USA. Electronic address: rpdoyle@syr.edu. |
| Source: | Metabolism: clinical and experimental [Metabolism] 2026 Jan; Vol. 174, pp. 156414. Date of Electronic Publication: 2025 Oct 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0375267 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8600 (Electronic) Linking ISSN: 00260495 NLM ISO Abbreviation: Metabolism Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41093057 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ashlaw+EF%22">Ashlaw EF</searchLink>; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA.<br /><searchLink fieldCode="AU" term="%22Elfers+CT%22">Elfers CT</searchLink>; Seattle Children's Research Institute, Seattle, WA, 98195, USA; University of Washington School of Medicine, Department of Pediatrics, Seattle, WA, 98195, USA.<br /><searchLink fieldCode="AU" term="%22Chichura+KS%22">Chichura KS</searchLink>; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA.<br /><searchLink fieldCode="AU" term="%22Miranda+IC%22">Miranda IC</searchLink>; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA.<br /><searchLink fieldCode="AU" term="%22McGivney+A%22">McGivney A</searchLink>; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA.<br /><searchLink fieldCode="AU" term="%22Chepurny+OG%22">Chepurny OG</searchLink>; State University of New York, Upstate Medical University, Department of Medicine, Syracuse, NY, 13245, USA.<br /><searchLink fieldCode="AU" term="%22Holz+GG%22">Holz GG</searchLink>; State University of New York, Upstate Medical University, Department of Medicine, Syracuse, NY, 13245, USA; State University of New York, Upstate Medical University, Department of Pharmacology, Syracuse, NY, 13245, USA.<br /><searchLink fieldCode="AU" term="%22Mullins+G%22">Mullins G</searchLink>; Seattle Children's Research Institute, Seattle, WA, 98195, USA.<br /><searchLink fieldCode="AU" term="%22den+Hartigh+LJ%22">den Hartigh LJ</searchLink>; University of Washington, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, UW Medicine Diabetes Institute, Seattle, WA, 98195, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, 98195, USA.<br /><searchLink fieldCode="AU" term="%22Roth+CL%22">Roth CL</searchLink>; Seattle Children's Research Institute, Seattle, WA, 98195, USA; University of Washington School of Medicine, Department of Pediatrics, Seattle, WA, 98195, USA. Electronic address: Christian.roth@seattlechildrens.org.<br /><searchLink fieldCode="AU" term="%22Doyle+RP%22">Doyle RP</searchLink>; Syracuse University, Department of Chemistry, 111 College Place, Syracuse, NY, 13244, USA; State University of New York, Upstate Medical University, Department of Medicine, Syracuse, NY, 13245, USA; State University of New York, Upstate Medical University, Department of Pharmacology, Syracuse, NY, 13245, USA. Electronic address: rpdoyle@syr.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220375267%22">Metabolism: clinical and experimental</searchLink> [Metabolism] 2026 Jan; Vol. 174, pp. 156414. <i>Date of Electronic Publication: </i>2025 Oct 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0375267 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-8600 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200260495%22">00260495 </searchLink><i>NLM ISO Abbreviation: </i>Metabolism <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41093057 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.metabol.2025.156414 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 156414 Titles: – TitleFull: A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ashlaw EF – PersonEntity: Name: NameFull: Elfers CT – PersonEntity: Name: NameFull: Chichura KS – PersonEntity: Name: NameFull: Miranda IC – PersonEntity: Name: NameFull: McGivney A – PersonEntity: Name: NameFull: Chepurny OG – PersonEntity: Name: NameFull: Holz GG – PersonEntity: Name: NameFull: Mullins G – PersonEntity: Name: NameFull: den Hartigh LJ – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Roth CL – PersonEntity: Name: NameFull: Doyle RP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1532-8600 Numbering: – Type: volume Value: 174 Titles: – TitleFull: Metabolism: clinical and experimental Type: main |
| ResultId | 1 |